| |
|
|
| Botox® |
|
| |
“Validation of a Patient-Reported Outcome (PRO) Measure to Assess Treatment Satisfaction in Facial Lines” June 23, 2010 - April 2011
|
| |
|
| |
MapiValues:"Instrument Development and Validation Study in Upper Facial Lines" November 2008
|
| |
|
| |
"A Prospective, Double-Blind, Randomized, Parallel Group, Dose-Ranging Study of Botox® in Female Subjects with Vertical Lip Lines" January 2008
|
| |
|
|
“A Placebo Controlled Study to Assess Patient-Reported Outcomes in Subjects Receiving BOTOX® (Botulinum Toxin Type A) for Treatment of Moderate to Severe Glabellar Rhytids” April 2005 - July 2005.
|
| |
|
| Dysport® |
|
|
"A Phase III, Randomized, Placebo-controlled, Multicenter, double-blind Study to Assess the Long-Term Safety and Duration of Efficacy of Reloxin® in the Correction of Moderate to Severe Glabellar Lines" January 2007- June 2007
|
| |
|
|
“A Phase III, Open-Label, Multicenter Study to Assess the Long-Term Safety of Repeat Administrations of 52120 in the Treatment of Glabellar Lines” September 2004-October 2005.
|
| |
|
| Injectable Fillers |
|
|
"Perlane®-L 27G Terumo Needle Evaluation Project" January-February 2012
|
| |
|
| |
"Perlane®-L 27G Terumo Needle Evaluation Project" October-November 2011
|
| |
|
|
“A Randomized, Evaluator-Blinded No-Treatment-Controlled Study of the Effectiveness and Safety of Restylane® in the Augmentation of Soft Tissue Fullness of the Lips” June 2009
|
| |
|
| |
"A Randomized, Double-Blind, Multi-Center Comparison of the Safety and Efficacy of Coapt Gel and Coapt Gel Plus versus Restylane® for the Correction of Nasolabial Folds" November 2008
|
| |
|
| |
“Isolagen Technologies, Phase III Study for the treatment of Nasolabial Fold Creases” November 2006 - November 2008
|
| |
|
|
"Sensitization Perlane® vs. Restylane® Study” July 2005 – December 2005
|
| |
|
| Fat Reduction |
|
| |
“A Randomized, Sham-Controlled Evaluation of the Safety and Effectiveness of Treatment of Adipose Tissue using a Focused Ultrasound Device” August 2009
|
| |
|
|
"A Multicenter, Randomized, Controlled Study with Independent, Masked Assessment, to Evaluate the Safety and Efficacy of the UltraShape® Contour Plus System, for Non-invasive Abdominal Fat Reduction for the Purpose of Body Contouring" September 2008
|
| |
|
| Latisse® |
|
| |
“A non-interventional, observational and medical records review of patient outcomes with bimatroprost ophthalmic solution 0.03% (Latisse®) for the treatment of hypotrichosis of the eyelashes.” November 2010- November 2011
|
| |
|
| |
"To Assess Patient Eyelash Growth. A Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel Study of the Safety and Efficacy of Once-Daily Bilateral Upper Eyelid Margin Administration of Bimatoprost 0.03% Solution Compared with Once-Daily Bilateral Administration of Vehicle in Subjects to Promote Upper Eyelash Growth" April 2007-September 2007
|
| |
|
| Dermatology |
|
|
“A Phase 4, Open-Label, Multi-center, Community-based, 12-Week Trial Assessment of Effectiveness, Safety, and Subject Satisfaction With Oracea® Capsules 40 mg When Used as Monotherapy or as Add-On Therapy to Existing Topical Regimens for the Treatment of Rosacea” April 2009
|
| Other |
|
|
“Multi-center prospective study: Incidence of cosmetic dermatologic adverse events” June 2011-August 2011
|
| |
|
| |
"A Phase 2, Double-Blind, Randomized. 4-Arm, Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of a Single Dose of RT001 Topical Gel for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults" April 2010-July 2010
|
| |
|
| |
|
